Michael Nally - Net Worth and Insider Trading
Michael Nally Net Worth
The estimated net worth of Michael Nally is at least $45 Million dollars as of 2026-08-16. Michael Nally is the CEO of Generate Biomedicines Inc and owns about 2,889,154 shares of Generate Biomedicines Inc (GENB) stock worth over $45 Million. Details can be seen in Michael Nally's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Nally has not made any transactions after 2026-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Nally
Michael Nally Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Nally owns 4 companies in total, including Merck & Co Inc (MRK) , PPG Industries Inc (PPG) , and Merck & Co Inc (MRKPRB.PFD) among others .
Click here to see the complete history of Michael Nally’s form 4 insider trades.
Insider Ownership Summary of Michael Nally
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MRK | Merck & Co Inc | 2019-05-03 | EVP & Chief Marketing Officer |
| PPG | PPG Industries Inc | 2021-02-18 | director |
| MRKPRB.PFD | Merck & Co Inc | 2019-05-03 | EVP & Chief Marketing Officer |
 | | 2026-02-26 | director & Chief Executive Officer |
Michael Nally Latest Holdings Summary
Michael Nally currently owns a total of 1 stock. Michael Nally owns 2,889,154 shares of Generate Biomedicines Inc (GENB) as of March 4, 2026, with a value of $45 Million.
Latest Holdings of Michael Nally
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GENB | Generate Biomedicines Inc | 2026-03-04 | 2,889,154 | 15.63 | 45,143,031 |
Holding Weightings of Michael Nally
Michael Nally Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Nally has made a total of 1 transactions in Generate Biomedicines Inc (GENB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Generate Biomedicines Inc is the acquisition of 20,000 shares on March 4, 2026, which cost Michael Nally around $240,000.
Insider Trading History of Michael Nally
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Michael Nally Trading Performance
GuruFocus tracks the stock performance after each of Michael Nally's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Nally is 26.72%. GuruFocus also compares Michael Nally's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Nally within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Nally's insider trading performs compared to the benchmark.
Performance of Michael Nally
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.53 | | | | | |
| Relative Return to S&P 500(%) | 22.71 | | | | | |
Michael Nally Ownership Network
Ownership Network List of Michael Nally
Ownership Network Relation of Michael Nally
Michael Nally Owned Company Details
What does Merck & Co Inc do?
Who are the key executives at Merck & Co Inc?
Michael Nally is the EVP & Chief Marketing Officer of Merck & Co Inc. Other key executives at Merck & Co Inc include Chief Marketing Officer Chirfi Guindo , EVP&Pres & Merck Animal Heallth Richard R. Deluca , and EVP & General Counsel Jennifer Zachary .
Merck & Co Inc (MRK) Insider Trades Summary
Over the past 18 months, Michael Nally made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 65,000 shares made by Chirfi Guindo , a net sale of 89,055 shares made by Richard R. Deluca , and a net sale of 201,888 shares made by Jennifer Zachary .
In summary, during the past 3 months, insiders sold 228,238 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 228,238 shares. During the past 18 months, 592,110 shares of Merck & Co Inc (MRK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 592,110 shares.
Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merck & Co Inc Insider Transactions
Michael Nally Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Nally. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Michael Nally's mailing address is: Pittsburgh Pa 15272.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
